Skip to main navigation Skip to search Skip to main content

Quantum dots encapsulated with curcumin inhibit the growth of colon cancer, breast cancer and bacterial cells

Research output: Contribution to journalArticlepeer-review

Abstract

To synthesize and examine the impact of free Eudragit® RS 100 nanoparticles (LN01), Quantum dots curcumin-loaded Eudragit RS 100 nanoparticles (LN04), and un-encapsulated curcumin nanoparticles (LN06) on cancerous and bacterial cells. Materials & methods: The LN01, LN04, LN06 were synthesized and characterized by Fourier transform infrared, ζ potential, UV-Vis spectroscopy, transmission electron microscopy and scanning electron microscopy and their biological activities were evaluated. Results: LN04 profoundly inhibited the growth of colon (HCT-116) cancerous cells (10.64% cell viability) and breast cancer (MCF-7) cells (10.32% cell viability) with compared to LN01 and LN06. Normal cells (HEK-293) did not show any inhibition after treatments. In addition, LN04 show better inhibitory action on bacterial growth compared with LN01 and LN06. Conclusion: We suggest that LN04 selectively target cancerous and bacterial cells and therefore possess potential anticancer and antibacterial capabilities.

Original languageEnglish
Pages (from-to)969-980
Number of pages12
JournalNanomedicine
Volume15
Issue number10
DOIs
StatePublished - Apr 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • antibacterial agent
  • anticancer agent
  • curcumin
  • drug delivery
  • quantum dots

Fingerprint

Dive into the research topics of 'Quantum dots encapsulated with curcumin inhibit the growth of colon cancer, breast cancer and bacterial cells'. Together they form a unique fingerprint.

Cite this